Back

Effects of sacubitril/valsartan versus enalapril on NT-proBNP and hs-troponin T in patients with heart failure due to Chagas disease: insights from the PARACHUTE-HF trial

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: HFrEF therapy: beyond current standards Heart Failure with Reduced Ejection Fraction (HFrEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Luis Eduardo Echeverria

Floridablanca (Colombia)

6 More presentations in this session

Presentation thumbnail
Effect of traditional Chinese medicine Qiliqiangxin in patients With HFrEF treated with sacubitril/valsartan: the QUEST trial
Doctor I. Cheang (Nanjing, CN)
Abstract
Presentation thumbnail
Integrating six-minute walk distance into a simple multimarker score improves risk stratification in advanced HFrEF
Doctor M. Chudy (Bratislava, SK)
Abstract
Presentation thumbnail
Multicentre validation of an AI model for detection of reduced left ventricular ejection fraction
Mr R. Rama (Groningen, NL)
Abstract
Presentation thumbnail
NT-proBNP and UACR for outcome prediction in HFrEF
Doctor N. Panagiotides (Vienna, AT)
Abstract
Presentation thumbnail
Validation of an AI‑ECG tool to detect left ventricular systolic dysfunction in community-based patients with suspected heart failure and elevated NT‑proBNP.
Doctor U. Razzaq (Glasgow, GB)
Abstract

Access the full session

Session thumbnail
HFrEF therapy: beyond current standards

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Sacubitril/valsartan in HFrEF patients with low NT-proBNP levels: any benefit?
29 June 2021
thumbnail
Congress Presentation
Predictive value of novel circulating biomarkers in chagas disease: the brazilian chagas disease cohort
27 August 2022
thumbnail
Congress Session
Ask the Trialists - PARACHUTE-HF
1 September 2025
thumbnail
Congress Presentation
NT-proBNP and high-sensitivity cardiac troponin T to diagnose cardiac amyloidosis
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources